Latest News

This ETF provides the kind of growth and income profile that could do really well.

Cathie Wood remains very bullish on Tesla stock.

Bank of New York Mellon (NYSE:BNY) Chief Financial Officer Dermot McDonogh said the company’s recent progress has been driven by expense discipline, a revamped commercial model and a cultural shift aimed at making the firm more ambitious and client-focused. Speaking at an investor conference, McDon

These pipeline companies are cashing in on the AI data center power boom.

Yes, investors should be worried about an AI bubble because Wall Street has a long history of going to extremes.

Coca-Cola may be a Goldilocks investment in a high-bond-yield/low-equity-yield world.

AI Custom Web Development Services for Modern BusinessesIn today’s digital-first business environment, a high-quality website is more than an online presen

Cathie Wood just bought more shares of Archer Aviation for her company's flagship ETF.

Tech stocks delivered huge returns over the past decade, but there's a catch.

Equinix (NASDAQ:EQIX) sees enterprise adoption of artificial intelligence accelerating demand for higher-density data center capacity, interconnection services and latency-sensitive infrastructure, executives said during a Barclays conference discussion. Arquelle Shaw, Equinix’s President of the Am

The stock sits below where it closed on day one, even though revenue nearly doubled last quarter.

Main Street Capital offers an attractive, well-supported yield, and the drawdown has made the valuation look reasonable again.

Lucid's partnerships with driverless-car developers provide a critical source of revenue.

I revised my estimates higher for this booming semiconductor company.

Higher gas prices are making EVs more attractive to car buyers.

Hyperscalers will spend an estimated $850 billion on data centers in 2026.

AbbVie's market-beating days don't seem to be over yet.

Increasing geopolitical tensions have boosted demand for Planet Labs' products.

The opportunity cost of capital is increasing, and investors need to consider the implications.

Pfizer has a history of developing treatments that generate billions in sales.

Despite rising input costs, management is finding ways to improve margins.

The two companies are back doing what they do best.

Nike shares continue to drop, with no relief for investors.

A merger makes sense in terms of management efficiency, but massive valuations complicate matters.

Aris Bogdaneris, Group Head of Canadian Banking at Bank of Nova Scotia (NYSE:BNS), said the lender is seeing progress from a strategy centered on deepening primary customer relationships, diversifying revenue sources and maintaining pricing and cost discipline. Speaking at a Barclays event, Bogdane